174 related articles for article (PubMed ID: 9379793)
1. [New discoveries on antidepressive treatment: serotonin is the key].
Evenden J
Lakartidningen; 1997 Sep; 94(38):3262-6. PubMed ID: 9379793
[No Abstract] [Full Text] [Related]
2. Is there action beyond receptors?
Hrdina PD
J Psychiatry Neurosci; 1993 Mar; 18(2):57-9. PubMed ID: 8384874
[No Abstract] [Full Text] [Related]
3. A possible role of serotonin receptors in antidepressant drug action.
Snyder SH; Peroutka SJ
Pharmacopsychiatria; 1982 Jul; 15(4):131-4. PubMed ID: 7146092
[No Abstract] [Full Text] [Related]
4. Serotonin receptor binding sites: is there pharmacological and clinical significance?
Leysen J
Med Biol; 1983 Jun; 61(3):139-43. PubMed ID: 6314066
[No Abstract] [Full Text] [Related]
5. 5-HT7 receptor antagonists as a new class of antidepressants.
Mnie-Filali O; Lambás-Señas L; Zimmer L; Haddjeri N
Drug News Perspect; 2007 Dec; 20(10):613-8. PubMed ID: 18301795
[TBL] [Abstract][Full Text] [Related]
6. [Clinical application of serotonin antagonists in the treatment of hypertension].
Deguchi F; Saito T; Inagaki Y
Nihon Rinsho; 1989 Sep; 47(9):2058-63. PubMed ID: 2593279
[No Abstract] [Full Text] [Related]
7. Mode of action of antidepressant drugs.
Sulser F
J Clin Psychiatry; 1983 May; 44(5 Pt 2):14-20. PubMed ID: 6406444
[No Abstract] [Full Text] [Related]
8. Effects of antipsychotic drugs on serotonin receptors.
Meltzer HY; Nash JF
Pharmacol Rev; 1991 Dec; 43(4):587-604. PubMed ID: 1685568
[No Abstract] [Full Text] [Related]
9. 5-HT1A receptors and 5-HT1A-mediated responses: effect of treatments that modify serotonergic neurotransmission.
Frazer A; Hensler JG
Ann N Y Acad Sci; 1990; 600():460-74; discussion 474-5. PubMed ID: 2174665
[No Abstract] [Full Text] [Related]
10. The marketing of 5-hydroxytryptamine: depression or anxiety?
Healy D
Br J Psychiatry; 1991 Jun; 158():737-42. PubMed ID: 1873625
[No Abstract] [Full Text] [Related]
11. Independent evaluation of new drugs.
Ball CJ
Br J Psychiatry; 1991 Oct; 159():586-7. PubMed ID: 1661200
[No Abstract] [Full Text] [Related]
12. If at first you do succeed.
Lancet; 1991 Mar; 337(8742):650-1. PubMed ID: 1671998
[No Abstract] [Full Text] [Related]
13. [The world of serotonin and its receptors. Physiopathologic, clinical, and therapeutic aspects].
Marco Igual M
Med Clin (Barc); 1993 Jun; 101(4):144-53. PubMed ID: 8355545
[No Abstract] [Full Text] [Related]
14. Depression and serotonin: a never ending story.
Marazziti D
Curr Drug Targets; 2013 May; 14(5):513. PubMed ID: 23547753
[No Abstract] [Full Text] [Related]
15. [Antidepressive agents: classification and mechanism of action].
Cuenca E; Alamo C; Coullaut-Jáuregui J
Rev Clin Esp; 1997 Nov; 197 Suppl 3():44-7. PubMed ID: 9477690
[No Abstract] [Full Text] [Related]
16. Shifting depression.
Campbell IC; Marsden K; Powell JF
Psychol Med; 1994 May; 24(2):271-3. PubMed ID: 8084925
[No Abstract] [Full Text] [Related]
17. 5-HT7, neurogenesis and antidepressants: a promising therapeutic axis for treating depression.
Nandam LS; Jhaveri D; Bartlett P
Clin Exp Pharmacol Physiol; 2007; 34(5-6):546-51. PubMed ID: 17439430
[TBL] [Abstract][Full Text] [Related]
18. Animal models in obsessive compulsive disorder.
Olivier B
Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():27-9. PubMed ID: 1517553
[No Abstract] [Full Text] [Related]
19. Serotonergic mechanisms: a potential link between affective disorders and cardiovascular risk.
Escolar G; Díaz-Ricart M; Gomez-Gil E; Serra M; Gasto C; Bozzo J; Galán AM
Drugs Today (Barc); 2005 Nov; 41(11):721-43. PubMed ID: 16395413
[TBL] [Abstract][Full Text] [Related]
20. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
Ressler KJ; Nemeroff CB
Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
